KogeneBiotech is a leading company in the in-vitro diagnostics industry and has developed the 1st SARS-CoV-2 Real-time PCR Kit in South Korea, January 2020. We are a representative with a significant contribution in the early diagnosis and prevention of the spread of COVID-19 successfully. KogeneBiotech – the first mover of the Real-time PCR assay – has developed more than 1,000 PCR Kits. As a result, we have established an extensive product portfolio in emerging diseases, clinical diagnostics, food safety, animal diseases, and pathogens. We strive to ensure and improve public healthcare while maintaining continuous cooperation with the government authorities, the national research institutes, the great hospitals, and medical centers.
| Website | http://www.kogene.co.kr |
| Revenue | $1 million |
| Employees | 8 (6 on RocketReach) |
| Founded | 2000 |
| Phone | +966 12 657 9938 |
| Industry | Biotechnology, Business Services General, Business Services |
| Keywords | Real Time Pcr, In Vitro Diagnostics, Molecular Diagnostics, Diagnostic Kits, Molecular Testing, Sars Cov 2 Testing, Covid 19 Testing, Infectious Disease Diagnostics, Clinical Diagnostics, Medical Diagnostics, Healthcare Diagnostics, Diagnostic Solutions, Point Of Care Diagnostics, Rapid Diagnostics, Diagnostic Tools, Disease Diagnostics, Diagnostic Reagents, Biotechnology |
| Competitors | Roche, Thermo Fisher Scientific, Abbott, BD, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +45 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular KogeneBiotech employee's phone or email?
The KogeneBiotech annual revenue was $1 million in 2026.
Myoah Baek is the Vice President of KogeneBiotech.
6 people are employed at KogeneBiotech.
The NAICS codes for KogeneBiotech are [541713, 54171, 5417, 54, 541].
The SIC codes for KogeneBiotech are [87, 873].